Journal of Global Pharma Technology
Volume 12 Issue 12 (2020) Dec. 2020

Empagliflozin Managed Type 2 Diabetes Mellitus in Insulin induced Hypertension: A case report

Raja A (M.D Department of General Medicine, Government Medical College Hospital)
Sadagoban GK (JSS College of Pharmacy, JSS Academy of Higher Education & Research Ooty)
Jemi Rachel Shaji (JSS College of Pharmacy, JSS Academy of Higher Education & Research Ooty)
Renita Castelino (JSS College of Pharmacy, JSS Academy of Higher Education & Research Ooty, Tamilnadu)
Swathi Swaroopa Borra (JSS College of Pharmacy, JSS Academy of Higher Education & Research Ooty, Tamilnadu)



Article Info

Publish Date
30 Nov 2020

Abstract

Insulin is an essential hormone and has been the cornerstone in the therapy of Diabetes Mellitus. This case highlights insulin-induced hypertension in a type 2 DM patient, managed adequately with empagliflozin. A 60-year female with Diabetic Nephropathy & Hypothyroidism presented with elevated blood pressure after a week of insulin administration. An elevation in the patient’s blood pressure corresponding to the administration of insulin was observed. De-challenge and re-challenge of insulin with dose adjustment, resulted in sudden spike & decrease of blood pressure, thereby pointing a suspicion towards a relation between insulin and hypertension. Discontinuation of insulin and replacement with oral hypoglycemics has resulted in controlled blood pressure levels.

Copyrights © 2020






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...